The importance of HLA-B27 in the pathogenesis of ankylosing spondylitis is uncertain: current evidence favours a role for the B27 molecule itself. The possibility that quantitative differences in HLA-B27 expression may exist between patients with ankylosing spondylitis, family members, and control subjects positive for B27 was examined using appropriate monoclonal antibodies, flow cytometry, and a 'model lymphocyte' coated with a known number of mouse immunoglobulin binding sites. No differences were found between the groups. HLA-A2, examined for comparison, was expressed in greater amounts than HLA-B27, but each contributed only 10-20% of the total class I antigens. Homozygotes expressed twice the amount of antigen expressed by heterozygotes. Synovial lymphocytes expressed more class I antigens than peripheral lymphocytes.
Although many human diseases are associated with particular major histocompatibility complex (MHC) groups' the association between ankylosing spondylitis and HLA-B27 is one of the strongest known, with over 90% of affected subjects being HLA-B27 positive.2 3 It is also one of the few examples of a class I associated disease. Despite the strength of the association the part played by B27 in the pathogenesis of ankylosing spondylitis remains unclear. The gene linkage theory, which suggests that HLA-B27 is simply a marker for another closely linked ankylosing spondylitis gene, has little evidence to support it. Genetic studies4 and analysis of restriction fragment length polymorphisms5 have not found a distinct ankylosing spondylitis susceptibility gene. It seems increasingly likely that ankylosing spondylitis is the result of an immune response targeted to the B27 molecule itself. 6 The nature of this response is as yet unclear; the two major theories which have been proposed require either molecular mimicry7 or expression of a novel B27 associated structure in subjects with ankylosing spondylitis.' Clearly the two theories presupposeq-xpression of the B27 antigen on relevant target tissues.
Although class I antigens are widely expressed9 they are by no means universal. Enhanced expression in response to some cytokines has been shown in vitro'0 and in vivo" 12 We have set out to examine differences in total class I and HLA-B27 expression in subjects with ankylosing spondylitis, their family members, and HLA-B27 positive healthy controls using appropriate monoclonal antibodies and flow cytometric analysis. Relative differences were sought using mean fluorescent channel as a measure of bound antibody. An attempt was made to derive actual numbers of class I molecules using a standard ' Incubations for microbeads were performed at room temperature with a washing solution of 0-05% Tween/1% BSA-PBS (pH 7-4) and the beads were not fixed before analysis. Otherwise the beads were treated in the same way as cells. Saturating concentrations were used throughout. All samples using microbeads were analysed in triplicate. Differences between the groups were determined using a paired t test. Correlations were determined by Pearson's correlation coefficient. Table 2 gives the characteristics of the studied groups. Mean disease duration in the group with ankylosing spondylitis was 18-9 years (range 4-32 years). The 2) showed a similar amount of class I antigen in all three groups. HLA-B27, though also constant, appeared to contributed only 10 Our work suggests that HLA-A and HLA-B alleles are not necessarily expressed in equal amounts: we found that HLA-A2 was expressed quantitatively more than HLA-B27. The two, however, contribute only around 10-20% of total class I antigens, adding up to about 60-80% for HLA-A and HLA-B alleles. This was confirmed by analysis of a subject homozygous for HLA-B27 and HLA-A2. Binding sites for these two alleles respectively were 101x105 and 144x105, totalling 245x105. The value for total class I was 31lIx 105, leaving about 21% to be accounted for by non-HLA-A and HLA-B antigens. The implication is that a large pool of HLA exists which is recognised by a monoclonal antibody against a common determinant of HLA A, B, and C, but which is not detected by antibodies against HLA-A and HLA-B specificities. This has been confirmed on lymphoblastoid cell lines26 27 The technique of measurement using Simply Cellular Microbeads makes several assumptions, the most questionable of which is that binding of antibody to the surface of the bead occurs in the same way as to the surface of the cell. Clearly, the cell surface is a complex structure composed of hundreds of different molecules, each carrying many antigenic determinants. The possibility that one of these influences the binding of monoclonal antibodies to an adjacent HLA molecule must be considerable. Moreover, as the bead binds all mouse immunoglobulin, this is likely to be to the Fc part of the immunoglobulin, whereas binding to the cell surface will be via the F(ab) fragment.
Results
We experienced technical problems in achieving saturation of beads. For the cells a point was clearly reached beyond which addition of further antibody did not lead to increased mean fluorescence channel. Although considerable 'flattening off of the curve was found with the beads, we were unable to show clearly a point of saturation. We conclude that non-specific binding of the antibody occurred at high concentrations to the surface of the bead. For our purposes we estimated saturation to occur at a point beyond which doubling of the antibody concentration resulted in a less than 1% increase in mean fluorescence channel (see fig 3) .
It should be noted, however, that the main alternative method of measurement (use of radiolabelled antibody) is also subject to potential errors-for example, chemical damage of reagents during iodination, or the appearance of radioactive iodine instead of tyrosine in the antigen combining sites. 25 How does this information assist our understanding of the pathogenesis of ankylosing spondylitis? We found no evidence that a simple quantitative difference in HLA-B27 exists to account for disease. The possibility remains that such differences exist in an earlier phase of the disease, perhaps even before it is clinically apparent, or that cell types more clearly associated with pathological changes in ankylosing spondylitis do show differences. In the latter context it is of interest that synovial lymphocytes express demonstrably more class I antigens than simultaneously obtained peripheral lymphocytes. In the single subject with ankylosing spondylitis studied here B27 
